DALLAS — November 7, 2016 — TissueGen® Inc., developer of ELUTE® fiber, enables controlled sustained delivery of sensitive pharmaceuticals and biologics from biodegradable fibers for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen works with leading pharmaceutical, therapeutic, and medical device companies to develop fiber and textile medical devices for use in drug delivery applications such as small diameter vascular grafts and stents, tissue and nerve regeneration, orthopedic devices and sutures.
TissueGen, Inc. will showcase ELUTE® fiber for advanced pharmaceutical and biologics delivery from biodegradable polymers in Booth 3013 at the Society for Neuroscience’s Neuroscience 2016 meeting. ELUTE fiber directly replaces traditional fibers in medical textiles to potentially improve clinical outcomes by delivering temperature sensitive therapeutics and live biologics directly at the site of implant.
At Neuroscience 2016, explore how TissueGen’s patented manufacturing process enables controlled sustained delivery of the broadest range of temperature-sensitive pharmaceuticals and biologics ever possible via biodegradable fiber-based devices to enable medical device developers to achieve breakthroughs across a broad range of medical applications.
Neuroscience 2016 will take place November 12-16, 2016 at the San Diego Convention Center, San Diego, CA.
Posted November 7, 2016
Source: TissueGen® Inc.